Mara Ghilardi

4.0k total citations · 1 hit paper
70 papers, 2.6k citations indexed

About

Mara Ghilardi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Mara Ghilardi has authored 70 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 34 papers in Pulmonary and Respiratory Medicine and 17 papers in Cancer Research. Recurrent topics in Mara Ghilardi's work include Colorectal Cancer Treatments and Studies (15 papers), Cancer Treatment and Pharmacology (12 papers) and Lung Cancer Treatments and Mutations (11 papers). Mara Ghilardi is often cited by papers focused on Colorectal Cancer Treatments and Studies (15 papers), Cancer Treatment and Pharmacology (12 papers) and Lung Cancer Treatments and Mutations (11 papers). Mara Ghilardi collaborates with scholars based in Italy and China. Mara Ghilardi's co-authors include Fausto Petrelli, Sandro Barni, Mary Cabiddu, Karen Borgonovo, Andrea Coinu, Veronica Lonati, Ivano Vavassori, Mary Cabiddu, Filippo Pietrantonio and Michele Ghidini and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Mara Ghilardi

67 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: A meta-analysis

2015 350 citations Fausto Petrelli, Andrea Coinu et al. profile →

Peers

Countries citing papers authored by Mara Ghilardi

Since Specialization

Citations

This map shows the geographic impact of Mara Ghilardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mara Ghilardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mara Ghilardi more than expected).

Fields of papers citing papers by Mara Ghilardi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mara Ghilardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mara Ghilardi. The network helps show where Mara Ghilardi may publish in the future.

Co-authorship network of co-authors of Mara Ghilardi

This figure shows the co-authorship network connecting the top 25 collaborators of Mara Ghilardi. A scholar is included among the top collaborators of Mara Ghilardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mara Ghilardi. Mara Ghilardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	First-line treatment of locally advanced cervical carcinoma: An updated systematic review and Bayesian network meta-analysis 2025 ·Cancer Treatment Reviews ·Fausto Petrelli, (unknown), Lorenza Bruschieri, Antonella Villa, Fulvia Milena Cribiù, Karen Borgonovo, Mara Ghilardi, Antonio Ghidini, Silvia Seghezzi, (unknown), Francesca Trevisan	0
2	Different Chemotherapy Regimens and Pathologic Complete Response in Triple-Negative Breast Cancer: An Updated Network Meta-Analysis of Phase 3 Trials 2024 ·Medicina ·(unknown), Gianluca Tomasello, Maria Chiara Parati, Antonio Ghidini, Michele Ghidini, Karen Borgonovo, Mary Cabiddu, Mara Ghilardi, (unknown), Donatella Gambini, Alberto Zaniboni, (unknown), Ornella Garrone	1
3	Prognostic Value of HER2-low Status in ER+ Early Breast Cancer: A Systematic Review and Meta-Analysis 2023 ·Anticancer Research ·(unknown), Carmen G. Rea, Maria Chiara Parati, Karen Borgonovo, Mara Ghilardi, Lorenzo Dottorini, Andrea Luciani, Michele Ghidini, Fiorella Ruatta, Ornella Garrone, Gianluca Tomasello	6
4	Vitamin D3 and COVID-19 Outcomes: An Umbrella Review of Systematic Reviews and Meta-Analyses 2023 ·Antioxidants ·Fausto Petrelli, (unknown), Karen Borgonovo, Mary Cabiddu, Giuseppina Dognini, Mara Ghilardi, Maria Chiara Parati, Daniela Petrò, Lorenzo Dottorini, Carmen G. Rea, Veronica Lonati, Andrea Luciani, Antonio Ghidini	12
5	Comparative efficacy of palbociclib, ribociclib and abemaciclib for ER+ metastatic breast cancer: an adjusted indirect analysis of randomized controlled trials 2019 ·Breast Cancer Research and Treatment ·Fausto Petrelli, Antonio Ghidini, Rebecca Pedersini, Mary Cabiddu, Karen Borgonovo, Maria Chiara Parati, Mara Ghilardi, Vito Amoroso, Alfredo Berruti, Sandro Barni	59
6	Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Treated With Targeted Therapies: A Systematic Review With a Meta-Analysis 2016 ·Clinical Genitourinary Cancer ·Fausto Petrelli, Andrea Coinu, Ivano Vavassori, Mary Cabiddu, Karen Borgonovo, Mara Ghilardi, Veronica Lonati, Sandro Barni	56
7	Predictive Factors for Reclassification and Relapse in Prostate Cancer Eligible for Active Surveillance: A Systematic Review and Meta-analysis 2016 ·Urology ·Fausto Petrelli, Ivano Vavassori, Mary Cabiddu, (unknown), Mara Ghilardi, Karen Borgonovo, Veronica Lonati, Sandro Barni	14
8	Response of conventional chondrosarcoma to gemcitabine alone: a case report 2015 ·PubMed ·Salvatore Provenzano, Nadia Hindi, Carlo Morosi, Mara Ghilardi, Paola Collini, Paolo G. Casali, Silvia Stacchiotti	6
9	FOLFIRINOX-Based Neoadjuvant Therapy in Borderline Resectable or Unresectable Pancreatic Cancer 2015 ·Pancreas ·Fausto Petrelli, Andrea Coinu, Karen Borgonovo, Mary Cabiddu, Mara Ghilardi, Veronica Lonati, Enrico Aitini, Sandro Barni	131
10	Long response to eribulin in breast cancer: a case report 2015 ·Future Oncology ·Karen Borgonovo, Fausto Petrelli, Mary Cabiddu, Mara Ghilardi, Andrea Coinu, Silvia Seghezzi, Sandro Barni	3
11	Oxaliplatin-based Chemotherapy: A New Option in Advanced Hepatocellular Carcinoma. A Systematic Review and Pooled Analysis 2014 ·Clinical Oncology ·Fausto Petrelli, Andrea Coinu, Karen Borgonovo, Mary Cabiddu, Mara Ghilardi, Veronica Lonati, Sandro Barni	39
12	Enzalutamide After Docetaxel and Abiraterone Acetate Treatment in Prostate Cancer: A Pooled Analysis of 10 Case Series 2014 ·Clinical Genitourinary Cancer ·Fausto Petrelli, Andrea Coinu, Karen Borgonovo, Mary Cabiddu, Mara Ghilardi, Veronica Lonati, Sandro Barni	19
13	Cisplatin or Not in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis 2013 ·PLoS ONE ·Fausto Petrelli, Alberto Zaniboni, Andrea Coinu, Mary Cabiddu, Mara Ghilardi, Giovanni Sgroi, Sandro Barni	25
14	Platinum rechallenge in patients with advanced NSCLC: A pooled analysis 2013 ·Lung Cancer ·Fausto Petrelli, Andrea Coinu, Mary Cabiddu, Mara Ghilardi, Mara Ardine, Sandro Barni	25
15	FOLFIRI-Bevacizumab As First-Line Chemotherapy in 3500 Patients With Advanced Colorectal Cancer: A Pooled Analysis of 29 Published Trials 2013 ·Clinical Colorectal Cancer ·Fausto Petrelli, Karen Borgonovo, Mary Cabiddu, Mara Ghilardi, Veronica Lonati, (unknown), (unknown), Giordano Beretta, Sandro Barni	49
16	A novel perspective for an orphan problem: Old and new drugs for the medical management of malignant ascites 2010 ·Critical Reviews in Oncology/Hematology ·Sandro Barni, Mary Cabiddu, Mara Ghilardi, Fausto Petrelli	29
17	What Else in Gemcitabine-Pretreated Advanced Pancreatic Cancer? An Update of Second Line Therapies 2010 ·Reviews on Recent Clinical Trials ·Fausto Petrelli, Karen Borgonovo, Mara Ghilardi, Mary Cabiddu, Sandro Barni	8
18	Is there a role for maintenance therapy in non-small-cell lung cancer? An emerging issue 2009 ·Expert Review of Anticancer Therapy ·Fausto Petrelli, Mara Ghilardi, M. Cremonesi, Mary Cabiddu, Sandro Barni	1
19	Current data of targeted therapies for the treatment of triple-negative advanced breast cancer: empiricism or evidence-based? 2009 ·Expert Opinion on Investigational Drugs ·Fausto Petrelli, Mary Cabiddu, Mara Ghilardi, Sandro Barni	9
20	Treatment of locally advanced hepatocellular carcinoma by hepatic intra-artery chemotherapy: a pilot study 2004 ·Digestive and Liver Disease ·Roberto Mazzanti, (unknown), Enrico Mini, Stefania Nobili, B Neri, Umberto Arena, Pietro Pantaleo, Valentina Fabbroni, Mara Ghilardi, Riccardo Gattai, (unknown)	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact